A Retrospective Analysis of 1151 Chinese Women With Atypical Glandular Cells: Impact of High‐Risk Human Papilloma Virus Status and Age on Cervical and Endometrial Neoplasia Risk
- 9 June 2025
- journal article
- Published by Wiley in Diagnostic Cytopathology
- Vol. 53 (9) , 454-461
Abstract
Objective: To investigate the clinical significance of high‐risk human papillomavirus (hrHPV) testing and age in women with atypical glandular cells (AGC) on Pap tests.Methods: We retrospectively analyzed the relationship between hrHPV and cytology co‐testing, follow‐up histopathology within 6 months, age, and other demographic features in a large cohort of AGC patients from a single Chinese academic institution.Results: Among1510 AGC patients, 1151, 1260, and 866 patients had histopathologic results, hrHPV co‐testing, and both, respectively. High‐grade squamous intraepithelial lesions (HSIL)/adenocarcinoma in situ (AIS) and worse lesions (HSIL/AIS+) and endometrial atypical hyperplasia (EAH)/endometrial carcinoma (EC) (EAH/EC+) were present in 27.8% (281/1009) and 25.1% (113/450) patients, respectively. hrHPV was positive in 34.5% (435/1260) patients. Among hrHPV+ patients with genotyping by the Aptima assay, 48.8% (125/256) had HPV16 and/or 18/45. Compared to hrHPV− patients, hrHPV+ women had a significantly increased risk of HSIL/AIS+ (OR: 10.958, 95% CI: 7.657–15.682), particularly with HPV16 and/or18/45 (OR: 3.556, 95% CI: 2.122–5.959; both p < 0.001). Among hrHPV− patients, those aged ≥ 40 years had higher risks of HSIL/AIS+ (including 18 HPV‐independent and 11 metastatic adenocarcinomas; OR: 5.882, 95% CI: 2.702–12.806) and EAH/EC+ (OR: 7.622, 95% CI: 3.188–18.225) compared to younger patients (both p < 0.001).Conclusions: Combining hrHPV testing and age effectively stratifies risks in AGC patients: hrHPV positivity predicts high‐grade cervical lesions, while older hrHPV‐negative women are more likely to have endometrial or extra‐uterine malignancies. These findings may optimize management of AGC patients with cumulative supportive data.Keywords
This publication has 22 references indexed in Scilit:
- Retrospective analysis of cytology and high‐risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesionsCancer Cytopathology, 2024
- Clinicopathological significance of atypical glandular cells on cervicovaginal Pap smearsDiagnostic Cytopathology, 2017
- Significance of high‐risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institutionCancer Cytopathology, 2016
- Clinical significance of atypical glandular cells in Pap tests: An analysis of more than 3000 cases at a large academic women's centerCancer Cytopathology, 2016
- High‐risk HPV testing in the management of atypical glandular cells: A systematic review and meta‐analysisInternational Journal of Cancer, 2015
- Prevalence and genotype distribution of human papillomavirus in cytology specimens containing atypical glandular cells: A case–control studyJournal of Clinical Virology, 2013
- Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population‐based studiesInternational Journal of Cancer, 2012
- Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC)European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- Assessment of reflex human papillomavirus DNA testing in patients with atypical endocervical cells on cervical cytologyCancer, 2008
- Weeding atypical glandular cell look‐alikes from the true atypical lesions in liquid‐based Pap tests: A reviewDiagnostic Cytopathology, 2006